PHARMACOGENOMIC DRUG INTERACTION
Clinical trials for PHARMACOGENOMIC DRUG INTERACTION explained in plain language.
Never miss a new study
Get alerted when new PHARMACOGENOMIC DRUG INTERACTION trials appear
Sign up with your email to follow new studies for PHARMACOGENOMIC DRUG INTERACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
DNA test aims to cut senior falls from meds
Knowledge-focused Recruiting nowThis study looks at whether using a person's DNA to guide their prescriptions can reduce harmful side effects, especially falls, in older adults who take five or more medications. About 1,000 people over 65 who have had a fall will provide a cheek swab for DNA testing. Half of th…
Matched conditions: PHARMACOGENOMIC DRUG INTERACTION
Phase: NA • Sponsor: Florida Atlantic University • Aim: Knowledge-focused
Last updated May 26, 2026 06:58 UTC
-
Gene test could stop drug reactions before they start
Knowledge-focused Recruiting nowThis study looks at whether testing people's genes before they start a new medicine can help doctors choose the right drug and dose to avoid side effects. About 66 adults getting a first-time prescription for one of 39 common drugs will be followed for 48 weeks. The goal is to se…
Matched conditions: PHARMACOGENOMIC DRUG INTERACTION
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 26, 2026 06:48 UTC
-
Gene test before your next prescription could save lives and money
Knowledge-focused Recruiting nowThis study looks at whether testing a patient's genes before giving them a new medicine can prevent side effects and make treatments work better. About 4,000 adults in the hospital or clinic who need a new drug will give a cheek swab. Half get their gene results right away to gui…
Matched conditions: PHARMACOGENOMIC DRUG INTERACTION
Phase: NA • Sponsor: NHS Greater Glasgow and Clyde • Aim: Knowledge-focused
Last updated May 26, 2026 06:43 UTC